Affymax, Takeda launch OMONTYS injection in US
The once-monthly erythropoiesis-stimulating agent (ESA) for anemia is co-marketed by Affymax and Takeda Pharmaceuticals USA (TPUSA) and distributed by TPUSA. Affymax chief executive officer John Orwin said, "Today’s
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.